Antiviral effect of amiodarone and its possible role in COVID-19: An appraisal.
作者信息
Lonare Snehal, Hazarika Mythili, Das Chandra Kr
机构信息
Department of Pharmacology and Toxicology, GADVASU, Ludhiana, Punjab, India.
Department of Psychiatry, Guwahati Medical College Hospital, Affiliated to Srimanta Sankaradeva University of Health Sciences, Assam, India.
出版信息
Indian J Pharmacol. 2020 Nov-Dec;52(6):533-534. doi: 10.4103/ijp.IJP_714_20.
Abstract
摘要
相似文献
1
Antiviral effect of amiodarone and its possible role in COVID-19: An appraisal.胺碘酮的抗病毒作用及其在 COVID-19 中的可能作用：一项评估。
Indian J Pharmacol. 2020 Nov-Dec;52(6):533-534. doi: 10.4103/ijp.IJP_714_20.
2
Amiodarone as a possible therapy for coronavirus infection.胺碘酮作为冠状病毒感染的一种可能治疗方法。
Eur J Prev Cardiol. 2021 Oct 13;28(12):e16-e18. doi: 10.1177/2047487320919233.
3
Antiviral activity of amiodarone in SARS-CoV-2 disease.胺碘酮在 SARS-CoV-2 疾病中的抗病毒活性。
Physiol Res. 2022 Dec 16;71(6):869-875. doi: 10.33549/physiolres.934974. Epub 2022 Nov 25.
4
Addressing SARS-CoV-2 viroporins with antiarrhythmic drugs.用抗心律失常药物治疗严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒孔蛋白
Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae254.
5
What is structural heart disease?什么是结构性心脏病？
Clin Cardiol. 2000 Jun;23(6):397-8. doi: 10.1002/clc.4960230603.
6
[Amiodaron: decades of administration].[胺碘酮：数十年的应用]
Ter Arkh. 2011;83(8):25-33.
7
Plausible Positive Effects of Statins in COVID-19 Patient.他汀类药物对 COVID-19 患者可能产生积极影响。
Cardiovasc Toxicol. 2021 Oct;21(10):781-789. doi: 10.1007/s12012-021-09674-x. Epub 2021 Jul 13.
8
Drugs used in heart disease. 1. Pharmacology--1.用于心脏病的药物。1. 药理学——1.
Nurs Times. 2002;98(18):43-6.
9
[Amiodarone in the treatment of arrhythmias].[胺碘酮治疗心律失常]
Duodecim. 1998;114(19):1923-36.
10
Cutaneous lesions and COVID-19: Cystic painful lesion in a case with positive SARS-CoV-2.皮肤病变与新型冠状病毒肺炎：1例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）检测阳性病例的囊性疼痛性病变
Dermatol Ther. 2020 Nov;33(6):e14266. doi: 10.1111/dth.14266. Epub 2020 Sep 14.
本文引用的文献
1
Safety and Efficacy of Amiodarone in a Patient With COVID-19.胺碘酮在一名新冠肺炎患者中的安全性和有效性
JACC Case Rep. 2020 Jul 15;2(9):1307-1310. doi: 10.1016/j.jaccas.2020.04.053. Epub 2020 May 29.
2
COVID-19 and the Heart.新型冠状病毒肺炎与心脏
Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.
3
Angiotensin Converting Enzyme 2: A Double-Edged Sword.血管紧张素转换酶2：一把双刃剑。
Circulation. 2020 Aug 4;142(5):426-428. doi: 10.1161/CIRCULATIONAHA.120.047049. Epub 2020 Mar 26.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus.体外和体内实验研究胺碘酮抗埃博拉病毒的活性。
J Infect Dis. 2018 Nov 22;218(suppl_5):S592-S596. doi: 10.1093/infdis/jiy345.
6
[Clinical aspects of treatment with amiodarone].[胺碘酮治疗的临床方面]
Herzschrittmacherther Elektrophysiol. 2017 Sep;28(3):307-316. doi: 10.1007/s00399-017-0516-0.
7
Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration.胺碘酮的治疗监测：药代动力学及效应与剂量/浓度关系的评估
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun;161(2):134-143. doi: 10.5507/bp.2017.016. Epub 2017 Mar 31.
8
Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.胺碘酮抑制丙型肝炎病毒生命周期的进入和组装步骤。
Clin Sci (Lond). 2013 Nov;125(9):439-48. doi: 10.1042/CS20120594.
9
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.胺碘酮可改变晚期内体，并在内体后水平抑制严重急性呼吸综合征冠状病毒感染。
Am J Respir Cell Mol Biol. 2008 Aug;39(2):142-9. doi: 10.1165/rcmb.2007-0217OC. Epub 2008 Feb 28.
Zotero 插件